Cogent Biosciences (COGT) Times Interest Earned (2017 - 2026)
Cogent Biosciences' (COGT) quarterly Times Interest Earned came in at -$15.18 in Q1 2026, up 99.92% year-on-year from -$7.59 in Q1 2025, and up 80.17% on a QoQ basis from -$76.53 in Q4 2025.
Cogent Biosciences (COGT) Times Interest Earned (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has 10 years of Times Interest Earned data on file, last reported at -$15.18 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.92% year-over-year to -$15.18 in Q1 2026; TTM through Mar 2026 was -$53.03, a 99.93% increase from a year earlier, with the FY2025 full-year figure at -$0.45, up 64.66% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$15.18, up from -$76.53 in the prior quarter.
- Over the last five years, Times Interest Earned for COGT reached as high as -$0.92 in Q2 2022 and fell as low as -$18733.2 in Q1 2025.
- Historically, Times Interest Earned has averaged -$1530.8 across 5 years, with a median of -$94.21 in 2022.
- Across the five-year window, Times Interest Earned plunged 48721.25% in 2023 and jumped 99.92% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$111.88 in 2022, then surged by 56.04% to -$49.18 in 2023, then tumbled by 581.89% to -$335.35 in 2024, then jumped by 77.18% to -$76.53 in 2025, then surged by 80.17% to -$15.18 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$15.18 in Q1 2026, -$76.53 in Q4 2025, and -$14.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | -15.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.18 |
| Dec 31, 2025 | -76.53 |
| Sep 30, 2025 | -14.50 |
| Jun 30, 2025 | -299.93 |
| Mar 31, 2025 | -18,733.25 |
| Jun 30, 2024 | -335.35 |
| Mar 31, 2024 | -990.54 |
| Dec 31, 2023 | -49.18 |
| Sep 30, 2023 | -346.40 |
| Jun 30, 2023 | -448.43 |
| Dec 31, 2022 | -111.88 |
| Sep 30, 2022 | -2.90 |
| Jun 30, 2022 | -0.92 |
| Mar 31, 2022 | -6.84 |
| Dec 31, 2021 | -31.19 |
| Sep 30, 2021 | -42.81 |
| Jun 30, 2021 | -3.79 |
| Mar 31, 2021 | -16.58 |
| Dec 31, 2020 | -14.14 |
| Sep 30, 2020 | -9.00 |